DAGM: A novel modelling framework to assess the risk of HER2-negative breast cancer based on germline rare coding mutations

BACKGROUND: Breast cancers can be divided into HER2-negative and HER2-positive subtypes according to different status of HER2 gene. Despite extensive studies connecting germline mutations with possible risk of HER2-negative breast cancer, the main category of breast cancer, it remains challenging to...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Mei, Fan, Yanhui, Wu, Zhi-Yong, Gu, Jin, Feng, Zhendong, Zhang, Qiangzu, Han, Shunhua, Zhang, Zhonghai, Li, Xu, Hsueh, Yi-Ching, Ni, Yanxiang, Li, Xiaoling, Li, Jieqing, Hu, Meixia, Li, Weiping, Gao, Hongfei, Yang, Ciqiu, Zhang, Chunming, Zhang, Liulu, Zhu, Teng, Cheng, Minyi, Ji, Fei, Xu, Juntao, Cui, Hening, Tan, Guangming, Zhang, Michael Q., Liang, Changhong, Liu, Zaiyi, Song, You-Qiang, Niu, Gang, Wang, Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220579/
https://www.ncbi.nlm.nih.gov/pubmed/34157485
http://dx.doi.org/10.1016/j.ebiom.2021.103446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220579/
https://www.ncbi.nlm.nih.gov/pubmed/34157485
http://dx.doi.org/10.1016/j.ebiom.2021.103446

Ejemplares similares